Ovarian Neoplasm — Trials

Ovarian Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,430 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 801–850 of 930 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06437353	Surufatinib Combined With Carboplatin/Paclitaxel and Surufatinib Combined With Olaparib as First-line and Maintenance Therapy for Newly Diagnosed High-risk Ovarian Cancer	recruiting	Phase 2	74	Anhui Provincial Cancer HospitalOTHER	1	Nov 27, 2024	clinicaltrials
NCT05824975	A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)	recruiting	Phase 1 / Phase 2	358	GI Innovation, Inc.INDUSTRY